Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Virtual Booth

S (-) AMLODIPINE BESILATE

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

180 API Suppliers, 42 USDMF, 45 CEP/COS, 27 JDMF, 36 EU WC, 77 KDMF, 27 NDC API, 61 Listed Suppliers

180 API Suppliers
42 USDMF
45 CEP/COS
27 JDMF
36 EU WC
77 KDMF
27 NDC API
61 Listed Suppliers

DEVELOPMENTS

20 Drugs in Development

20 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1717 FDF Dossiers, 471 FDA Orange Book, 898 Europe, 135 Canada, 69 South Africa, 144 Listed Dossiers

1717 FDF Dossiers
471 FDA Orange Book
898 Europe
135 Canada
69 South Africa
144 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE, TABLET;ORAL - EQ 5MG BASE, CAPSULE;ORAL - EQ 10MG BASE;20MG, CAPSULE;ORAL - EQ 10MG BASE;40MG, CAPSULE;ORAL - EQ 2.5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;20MG, CAPSULE;ORAL - EQ 5MG BASE;40MG, TABLET;ORAL - EQ 10MG BASE;14MG, TABLET;ORAL - EQ 2.5MG BASE;3.5MG, TABLET;ORAL - EQ 5MG BASE;7MG, TABLET;ORAL - EQ 10MG BASE;200MG, TABLET;ORAL - EQ 2.5MG BASE;200MG, TABLET;ORAL - EQ 5MG BASE;200MG, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;160MG, TABLET;ORAL - EQ 10MG BASE;320MG, TABLET;ORAL - EQ 5MG BASE;160MG, TABLET;ORAL - EQ 5MG BASE;320MG, TABLET;ORAL - EQ 10MG BASE;20MG, TABLET;ORAL - EQ 10MG BASE;40MG, TABLET;ORAL - EQ 5MG BASE;20MG, TABLET;ORAL - EQ 5MG BASE;40MG, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE
TABLET;ORAL - EQ 5MG BASE
CAPSULE;ORAL - EQ 10MG BASE;20MG
CAPSULE;ORAL - EQ 10MG BASE;40MG
CAPSULE;ORAL - EQ 2.5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;10MG
CAPSULE;ORAL - EQ 5MG BASE;20MG
CAPSULE;ORAL - EQ 5MG BASE;40MG
TABLET;ORAL - EQ 10MG BASE;14MG
TABLET;ORAL - EQ 2.5MG BASE;3.5MG
TABLET;ORAL - EQ 5MG BASE;7MG
TABLET;ORAL - EQ 10MG BASE;200MG
TABLET;ORAL - EQ 2.5MG BASE;200MG
TABLET;ORAL - EQ 5MG BASE;200MG
TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 10MG BASE;160MG
TABLET;ORAL - EQ 10MG BASE;320MG
TABLET;ORAL - EQ 5MG BASE;160MG
TABLET;ORAL - EQ 5MG BASE;320MG
TABLET;ORAL - EQ 10MG BASE;20MG
TABLET;ORAL - EQ 10MG BASE;40MG
TABLET;ORAL - EQ 5MG BASE;20MG
TABLET;ORAL - EQ 5MG BASE;40MG
TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;320MG
TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 5MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 22 SPI Pharma, 1 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 5 Kirsch Pharma, 1 Panvo Organics, 2 Cerata Pharmaceuticals LLP, 13 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 5 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 1 Avesta Pharma, 35 BASF, 1 CD Formulation, 3 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 3 Gloria Interchem, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 2 JJ Chemicals, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 23 Roquette, 16 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

1 Minakem
3 Rochem International Inc
22 SPI Pharma
1 Pharm-RX Chemical
8 Boai NKY Pharmaceuticals Ltd
6 Gangwal Healthcare
11 Nanjing Well Pharmaceutical
1 Shanghai Minbiotech
2 Pfanstiehl
5 Kirsch Pharma
1 Panvo Organics
2 Cerata Pharmaceuticals LLP
13 Dr. Paul Lohmann GmbH & Co. KGaA
4 ACG Worldwide
5 Actylis
2 Aeon Procare
1 Alcedo Pharmachem
10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
4 Ashland
1 Avesta Pharma
35 BASF
1 CD Formulation
3 Clariant
11 Corel Pharma Chem
7 DFE Pharma
1 Esteem Industries
2 Finar
13 Gangwal Chemicals
3 Gloria Interchem
5 Ideal Cures
5 Ingredion Pharma Solutions
2 JJ Chemicals
26 Kerry
4 Keval Exports
4 Kima Chemical
6 Lonza Capsugel
20 Microlex e.U
1 Nanjing Bold Chemical
2 Neelkanth MineChem
3 Nitika Pharmaceutical Specialities
2 Nomisma Healthcare
4 Novo Excipients
5 Pharmatrans-Sanaq
8 Pluviaendo
4 Prachin Pharmachem
1 Qianhao Chemical (Hebei) Co., Ltd
2 Qualicaps
23 Roquette
16 Seppic
7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
11 Sigachi Industries
4 Silverline Chemicals
3 The Dow Chemical Company
2 Ulanqab Kema New Material
1 Valens Pharmachem
4 Vasa Pharmachem
1 Vertellus

EXCIPIENTS BY APPLICATIONS

91 Fillers, Diluents & Binders, 59 Coating Systems & Additives, 49 Direct Compression, 47 Disintegrants & Superdisintegrants, 38 Solubilizers, 38 Thickeners and Stabilizers, 37 Granulation, 31 Lubricants & Glidants, 29 Controlled & Modified Release, 27 Topical, 25 Parenteral, 23 Chewable & Orodispersible Aids, 23 Film Formers & Plasticizers, 20 Taste Masking, 16 Co-Processed Excipients, 14 API Stability Enhancers, 13 Emulsifying Agents, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 8 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

91 Fillers, Diluents & Binders
59 Coating Systems & Additives
49 Direct Compression
47 Disintegrants & Superdisintegrants
38 Solubilizers
38 Thickeners and Stabilizers
37 Granulation
31 Lubricants & Glidants
29 Controlled & Modified Release
27 Topical
25 Parenteral
23 Chewable & Orodispersible Aids
23 Film Formers & Plasticizers
20 Taste Masking
16 Co-Processed Excipients
14 API Stability Enhancers
13 Emulsifying Agents
10 Surfactant & Foaming Agents
9 Empty Capsules
8 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 44 News #PharmaBuzz

1 Data Compilation #PharmaFlow
44 News #PharmaBuzz

GLOBAL SALES INFORMATION

49 US Medicaid Prescriptions, 36 Regulatory FDF Prices

49 US Medicaid Prescriptions
36 Regulatory FDF Prices

MARKET PLACE

47 APIs, 7 FDF Dossiers

47 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 195 Health Canada Patents

28 US Patents
195 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 3 USP, 7 JP, 1 Others

5 EDQM
3 USP
7 JP
1 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Reference Standard Reset all filters

7 All

01 7Amlodipine Besilate

filter Monograph in Japanese Pharmacopoeia Reset all filters

7 All

01 1Amlodipine Besilate

02 1Amlodipine Besilate Orally Disintegrating

03 1Amlodipine Besilate Tablets

04 1Besylate Tablets

05 1Candesartan Cilexetil and Amlodipine

06 1Tablets

07 1Blank

Reset Filter

Price Info

Product Main Page

01

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

01

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Amlodipine...

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test : I/ UV-VIS I/ IR

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

02

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia :

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test : A/ LC

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

03

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Amlodipine...

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C°C

Assay Test : U/ LC A/ LC

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

04

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Amlodipine...

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test : U/ LC A/ LC

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

05

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Tablets

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

06

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Candesarta...

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test : U/ LC D/ LC

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

07

Japanese Pharmacopoeia

Japan

AOCS Annual Meeting

Not Confirmed

Post an Enquiry

Japan

Virtual Booth

Digital Content

Amlodipine Besilate

Monograph in Japanese Pharmacopoeia : Besylate T...

Package Size : 150 mg

Price (¥) : 66,857

Storage Temperature °C : 25°C

Assay Test : A/ LC

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

S (-) AMLODIPINE BESILATE

S (-) AMLODIPINE BESILATE

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

180 API Suppliers

42 USDMF

45 CEP/COS

27 JDMF

36 EU WC

77 KDMF

27 NDC API

61 Listed Suppliers

DEVELOPMENTS

20 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1717 FDF Dossiers

471 FDA Orange Book

898 Europe

135 Canada

69 South Africa

144 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 2.5MG BASE

TABLET;ORAL - EQ 5MG BASE

CAPSULE;ORAL - EQ 10MG BASE;20MG

CAPSULE;ORAL - EQ 10MG BASE;40MG

CAPSULE;ORAL - EQ 2.5MG BASE;10MG

CAPSULE;ORAL - EQ 5MG BASE;10MG

CAPSULE;ORAL - EQ 5MG BASE;20MG

CAPSULE;ORAL - EQ 5MG BASE;40MG

TABLET;ORAL - EQ 10MG BASE;14MG

TABLET;ORAL - EQ 2.5MG BASE;3.5MG

TABLET;ORAL - EQ 5MG BASE;7MG

TABLET;ORAL - EQ 10MG BASE;200MG

TABLET;ORAL - EQ 2.5MG BASE;200MG

TABLET;ORAL - EQ 5MG BASE;200MG

TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE

TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 10MG BASE;160MG

TABLET;ORAL - EQ 10MG BASE;320MG

TABLET;ORAL - EQ 5MG BASE;160MG

TABLET;ORAL - EQ 5MG BASE;320MG

TABLET;ORAL - EQ 10MG BASE;20MG

TABLET;ORAL - EQ 10MG BASE;40MG

TABLET;ORAL - EQ 5MG BASE;20MG

TABLET;ORAL - EQ 5MG BASE;40MG

TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;160MG

TABLET;ORAL - EQ 10MG BASE;25MG;320MG

TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG

TABLET;ORAL - EQ 5MG BASE;25MG;160MG

TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

3 Rochem International Inc

22 SPI Pharma

1 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

11 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

5 Kirsch Pharma

TABLET;ORAL - EQ 10MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 10MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons